
Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188-Re in adult recurrent high-grade glioma
Casaco, Angel, López, Gerardo, García, Iván, Arsenio Rodríguez, José, Fernández, Ramsés, Figueredo, Javier, Torres, Leonel, Perera Pintado, Alejandro, Batista, Juan, Leyva, René, Peña, Yamilé, Amador,Volume:
7
Langue:
english
Journal:
Cancer Biology & Therapy
DOI:
10.4161/cbt.7.3.5414
Date:
March, 2008
Fichier:
PDF, 720 KB
english, 2008